Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 09 March 2020; doi:10.1038/s41391-020-0218-2Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 9, 2020 Category: Urology & Nephrology Authors: A. Finelli M. Komisarenko L. J. Martin N. Timilshina K. Jain J. Morris A. Zlotta G. Kulkarni N. Perlis T. van der Kwast A. Evans S. Ghai N. Fleshner S. M. H. Alibhai R. J. Hamilton Source Type: research

Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 09 March 2020; doi:10.1038/s41391-020-0222-6Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 9, 2020 Category: Urology & Nephrology Authors: Keiichiro Mori Noriyoshi Miura Hadi Mostafaei Fahad Quhal Reza Sari Motlagh Benjamin Pradere Shoji Kimura Takahiro Kimura Shin Egawa Alberto Briganti Pierre I. Karakiewicz Shahrokh F. Shariat Source Type: research

Racial disparity in the utilization of multiparametric MRI–ultrasound fusion biopsy for the detection of prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 09 March 2020; doi:10.1038/s41391-020-0223-5Racial disparity in the utilization of multiparametric MRI–ultrasound fusion biopsy for the detection of prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 9, 2020 Category: Urology & Nephrology Authors: Connor Hoge Sadhna Verma Daniel J. Lama Ilana Bergelson Monzer Haj-Hamed Sean Maynor Krishnanath Gaitonde Abhinav Sidana Source Type: research

Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations
Prostate Cancer and Prostatic Diseases, Published online: 05 March 2020; doi:10.1038/s41391-020-0217-3Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 5, 2020 Category: Urology & Nephrology Authors: Changxue Lu Landon C. Brown Emmanuel S. Antonarakis Andrew J. Armstrong Jun Luo Source Type: research

Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 03 March 2020; doi:10.1038/s41391-020-0211-9Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 3, 2020 Category: Urology & Nephrology Authors: Mitchell E. Gross David B. Agus Tanya B. Dorff Jacek K. Pinski David I. Quinn Olga Castellanos Patrick Gilmore Jean C. Shih Source Type: research

Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study
Prostate Cancer and Prostatic Diseases, Published online: 02 March 2020; doi:10.1038/s41391-020-0220-8Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 2, 2020 Category: Urology & Nephrology Authors: Kerri Beckmann Hans Garmo Bertil Lindahl Lars Holmberg P är Stattin Jan Adolfsson J. Kennedy Cruickshank Mieke Van Hemelrijck Source Type: research

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry
Prostate Cancer and Prostatic Diseases, Published online: 28 February 2020; doi:10.1038/s41391-020-0213-7Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 28, 2020 Category: Urology & Nephrology Authors: Oliver Sartor Andrew J. Armstrong Chiledum Ahaghotu David G. McLeod Matthew R. Cooperberg David F. Penson Philip W. Kantoff Nicholas J. Vogelzang Arif Hussain Christopher M. Pieczonka Neal D. Shore David I. Quinn Eric J. Small Elisabeth I. Heath Ronald F. Source Type: research

Androgen receptor variant-driven prostate cancer II: advances in clinical investigation
Prostate Cancer and Prostatic Diseases, Published online: 24 February 2020; doi:10.1038/s41391-020-0215-5Androgen receptor variant-driven prostate cancer II: advances in clinical investigation (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 24, 2020 Category: Urology & Nephrology Authors: Landon C. Brown Changxue Lu Emmanuel S. Antonarakis Jun Luo Andrew J. Armstrong Source Type: research

Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 24 February 2020; doi:10.1038/s41391-020-0214-6Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 24, 2020 Category: Urology & Nephrology Authors: Sounak Gupta Chad Vanderbilt Wassim Abida Samson W. Fine Satish K. Tickoo Hikmat A. Al-Ahmadie Ying-Bei Chen Sahussapont J. Sirintrapun Kalyani Chadalavada Gouri J. Nanjangud Ann Bialik Michael J. Morris Howard I. Scher Marc Ladanyi Victor E. Reuter Anura Source Type: research

Cytoreductive cryotherapy for newly diagnosed oligometastatic hormone-sensitive prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 19 February 2020; doi:10.1038/s41391-020-0216-4Cytoreductive cryotherapy for newly diagnosed oligometastatic hormone-sensitive prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 19, 2020 Category: Urology & Nephrology Authors: M. J. Connor M. Winkler H. U. Ahmed Source Type: research

Copy number alterations are associated with metastatic-lethal progression in prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 18 February 2020; doi:10.1038/s41391-020-0212-8Copy number alterations are associated with metastatic-lethal progression in prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 18, 2020 Category: Urology & Nephrology Authors: Xiaoyu Wang Catherine S. Grasso Kristina M. Jordahl Suzanne Kolb Yaw A. Nyame Jonathan L. Wright Elaine A. Ostrander Dean A. Troyer Raymond Lance Ziding Feng James Y. Dai Janet L. Stanford Source Type: research

Survival outcomes and risk group validation from SWOG S0925: a randomized phase II study of cixutumumab in new metastatic hormone-sensitive prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 13 February 2020; doi:10.1038/s41391-020-0210-xSurvival outcomes and risk group validation from SWOG S0925: a randomized phase II study of cixutumumab in new metastatic hormone-sensitive prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 13, 2020 Category: Urology & Nephrology Authors: Risa L. Wong Mai T. Duong Catherine M. Tangen Neeraj Agarwal Heather H. Cheng Nicholas J. Vogelzang Maha Hussain Ian M. Thompson Jr. David I. Quinn Evan Y. Yu Source Type: research

Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI
Prostate Cancer and Prostatic Diseases, Published online: 12 February 2020; doi:10.1038/s41391-020-0206-6Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 12, 2020 Category: Urology & Nephrology Authors: M. J. Connor M. A. Gorin H. U. Ahmed R. Nigam Source Type: research

Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 07 February 2020; doi:10.1038/s41391-020-0209-3Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 7, 2020 Category: Urology & Nephrology Authors: Yupeng Guan Haiyun Xiong Yupeng Feng Guolong Liao Tongyu Tong Jun Pang Source Type: research

Obesity-associated inflammation induces androgenic to estrogenic switch in the prostate gland
Prostate Cancer and Prostatic Diseases, Published online: 06 February 2020; doi:10.1038/s41391-020-0208-4Obesity-associated inflammation induces androgenic to estrogenic switch in the prostate gland (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 6, 2020 Category: Urology & Nephrology Authors: Bichen Xue Shulin Wu Christina Sharkey Shahin Tabatabaei Chin-Lee Wu Zhipeng Tao Zhiyong Cheng Douglas Strand Aria F. Olumi Zongwei Wang Source Type: research

Associations among statins, preventive care, and prostate cancer mortality
Prostate Cancer and Prostatic Diseases, Published online: 06 February 2020; doi:10.1038/s41391-020-0207-5Associations among statins, preventive care, and prostate cancer mortality (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 6, 2020 Category: Urology & Nephrology Authors: Abhishek Kumar Paul Riviere Elaine Luterstein Vinit Nalawade Lucas Vitzthum Reith R. Sarkar Alex K. Bryant John P. Einck Arno J. Mundt James D. Murphy Brent S. Rose Source Type: research

Timing of exercise for muscle strength and physical function in men initiating ADT for prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 04 February 2020; doi:10.1038/s41391-019-0200-zTiming of exercise for muscle strength and physical function in men initiating ADT for prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 4, 2020 Category: Urology & Nephrology Authors: Robert U. Newton Daniel A. Galv ão Nigel Spry David Joseph Suzanne K. Chambers Robert A. Gardiner Dickon Hayne Dennis R. Taaffe Source Type: research

A noninferiority within-person study comparing the accuracy of transperineal to transrectal MRI–US fusion biopsy for prostate-cancer detection
Prostate Cancer and Prostatic Diseases, Published online: 17 January 2020; doi:10.1038/s41391-020-0205-7A noninferiority within-person study comparing the accuracy of transperineal to transrectal MRI–US fusion biopsy for prostate-cancer detection (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 17, 2020 Category: Urology & Nephrology Authors: Yaara Ber Niv Segal Shlomit Tamir Ofer Benjaminov Maxim Yakimov Sivan Sela Daniel Halstauch Jack Baniel Daniel Kedar David Margel Source Type: research

GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome
Prostate Cancer and Prostatic Diseases, Published online: 13 January 2020; doi:10.1038/s41391-020-0202-xGLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 13, 2020 Category: Urology & Nephrology Authors: Salma Meziou Cassandra Ringuette Goulet H élène Hovington V éronique Lefebvre Étienne Lavallée Michelle Bergeron Herv é Brisson Audrey Champagne Bertrand Neveu Didier Lacombe Jean-Mathieu Beauregard Fran çois-Alexandre Buteau Julie Riopel Fr édér Source Type: research

A simplified Italian translation of the international prostate symptom score twists the reality in the aging male with lower urinary tract symptoms
Prostate Cancer and Prostatic Diseases, Published online: 13 January 2020; doi:10.1038/s41391-020-0203-9A simplified Italian translation of the international prostate symptom score twists the reality in the aging male with lower urinary tract symptoms (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 13, 2020 Category: Urology & Nephrology Authors: Riccardo Bertolo Chiara Cipriani Luca Pozzi Pierluigi Bove Source Type: research

“TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now
Prostate Cancer and Prostatic Diseases, Published online: 13 January 2020; doi:10.1038/s41391-020-0204-8“TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 13, 2020 Category: Urology & Nephrology Authors: Jeremy Grummet Michael A. Gorin Rick Popert Tim O ’Brien Alastair D. Lamb Boris Hadaschik Jan Philipp Radtke Florian Wagenlehner Eduard Baco Caroline M. Moore Mark Emberton Arvin K. George John W. Davis Richard J. Szabo Roger Buckley Andrew Loblaw Matth Source Type: research

Clinicopathologic features and outcomes of anterior-dominant prostate cancer: implications for diagnosis and treatment
Prostate Cancer and Prostatic Diseases, Published online: 03 January 2020; doi:10.1038/s41391-019-0199-1Clinicopathologic features and outcomes of anterior-dominant prostate cancer: implications for diagnosis and treatment (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 3, 2020 Category: Urology & Nephrology Authors: Sara M. Falzarano Yaw A. Nyame Jesse K. McKenney Christopher G. Przybycin Jianbo Li Andrew Stephenson Amr Fergany Ming Zhou Eric A. Klein Cristina Magi-Galluzzi Source Type: research

Feasibility of freehand MRI/US cognitive fusion transperineal biopsy of the prostate in local anaesthesia as in-office procedure—experience with 400 patients
Prostate Cancer and Prostatic Diseases, Published online: 02 January 2020; doi:10.1038/s41391-019-0201-yFeasibility of freehand MRI/US cognitive fusion transperineal biopsy of the prostate in local anaesthesia as in-office procedure—experience with 400 patients (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 2, 2020 Category: Urology & Nephrology Authors: Christian Wetterauer Osama Shahin Joel R. Federer-Gsponer Nicola Keller Stephen Wyler Hans Helge Seifert Maciej Kwiatkowski Source Type: research

A review of prostate cancer treatment impact on the CNS and cognitive function
Prostate Cancer and Prostatic Diseases, Published online: 16 December 2019; doi:10.1038/s41391-019-0195-5A review of prostate cancer treatment impact on the CNS and cognitive function (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 16, 2019 Category: Urology & Nephrology Authors: Charles Ryan Jeffrey S. Wefel Alicia K. Morgans Source Type: research

Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting
Prostate Cancer and Prostatic Diseases, Published online: 16 December 2019; doi:10.1038/s41391-019-0197-3Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 16, 2019 Category: Urology & Nephrology Authors: Lauren E. Howard Jingbin Zhang Nick Fishbane Amanda M. De Hoedt Zachary Klaassen Daniel E. Spratt Adriana C. Vidal Dechen Lin Megan P. Hitchins Sungyong You Michael R. Freeman Kosj Yamoah Elai Davicioni Stephen J. Freedland Source Type: research

Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up
Prostate Cancer and Prostatic Diseases, Published online: 13 December 2019; doi:10.1038/s41391-019-0198-2Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 13, 2019 Category: Urology & Nephrology Authors: Stefano Luzzago Michele Catellani Ettore Di Trapani Gabriele Cozzi Francesco A. Mistretta Roberto Bianchi Paola Pricolo Andrea Conti Eleonora Ancona Nicol ò Piacentini Sarah Alessi Giuseppe Renne Matteo Ferro Deliu-Victor Matei Gennaro Musi Barbara Alicj Source Type: research

Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study
Prostate Cancer and Prostatic Diseases, Published online: 11 December 2019; doi:10.1038/s41391-019-0196-4Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 11, 2019 Category: Urology & Nephrology Authors: Claudio Maurizio Pacella Gianluigi Patelli Gennaro Iapicca Guglielmo Manenti Tommaso Perretta Colleen P. Ryan Renato Esposito Giovanni Mauri Source Type: research

Prostate Cancer and Prostatic Diseases Best of Asia, 2019: challenges and opportunities
Prostate Cancer and Prostatic Diseases, Published online: 06 December 2019; doi:10.1038/s41391-019-0193-7Prostate Cancer and Prostatic Diseases Best of Asia, 2019: challenges and opportunities (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 6, 2019 Category: Urology & Nephrology Authors: Yao Zhu Stephen J. Freedland Dingwei Ye Source Type: research

Risk of dementia following androgen deprivation therapy for treatment of prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 29 November 2019; doi:10.1038/s41391-019-0189-3Risk of dementia following androgen deprivation therapy for treatment of prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 29, 2019 Category: Urology & Nephrology Authors: Anna Krasnova Matthew Epstein Maya Marchese Barbra A. Dickerman Alexander P. Cole Stuart R. Lipsitz Paul L. Nguyen Adam S. Kibel Toni K. Choueiri Shehzad Basaria Lorelei A. Mucci Maxine Sun Quoc-Dien Trinh Source Type: research

Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml
Prostate Cancer and Prostatic Diseases, Published online: 28 November 2019; doi:10.1038/s41391-019-0194-6Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 28, 2019 Category: Urology & Nephrology Authors: Ewa Witkowska-Patena Agnieszka Gi żewska Miros ław Dziuk Jolanta Mi śko Anna Budzy ńska Agata Wal ęcka-Mazur Source Type: research

Current use of stereotactic body radiation therapy for low and intermediate risk prostate cancer: A National Cancer Database Analysis
Prostate Cancer and Prostatic Diseases, Published online: 28 November 2019; doi:10.1038/s41391-019-0191-9Current use of stereotactic body radiation therapy for low and intermediate risk prostate cancer: A National Cancer Database Analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 28, 2019 Category: Urology & Nephrology Authors: Timothy D. Malouff William C. Stross Danushka S. Seneviratne Mark R. Waddle Byron C. May Steven J. Buskirk Katherine S. Tzou Source Type: research

Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT
Prostate Cancer and Prostatic Diseases, Published online: 27 November 2019; doi:10.1038/s41391-019-0181-yGermline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 27, 2019 Category: Urology & Nephrology Authors: Mahbubl Ahmed Chee Goh Edward Saunders Clara Cieza-Borrella Zsofia Kote-Jarai Fredrick R. Schumacher Ros Eeles Source Type: research

How can mpMRI help surgical planning in high risk prostate cancer?
Prostate Cancer and Prostatic Diseases, Published online: 25 November 2019; doi:10.1038/s41391-019-0192-8How can mpMRI help surgical planning in high risk prostate cancer? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 25, 2019 Category: Urology & Nephrology Authors: Lorenzo Bianchi Riccardo Schiavina Eugenio Brunocilla Source Type: research

A polymeric paste-drug formulation for intratumoral treatment of prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 25 November 2019; doi:10.1038/s41391-019-0190-xA polymeric paste-drug formulation for intratumoral treatment of prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 25, 2019 Category: Urology & Nephrology Authors: Claudia Kesch Veronika Schmitt Samir Bidnur Marisa Thi Eliana Beraldi Igor Moskalev Virginia Yago Mary Bowden Hans Adomat Ladan Fazil John K. Jackson Martin E. Gleave Source Type: research

Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia
Prostate Cancer and Prostatic Diseases, Published online: 19 November 2019; doi:10.1038/s41391-019-0186-6Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 19, 2019 Category: Urology & Nephrology Authors: Judith Stangl-Kremser Rodrigo Suarez ‐Ibarrola David D ’ Andrea Stephan M. Korn Mario Pones Gero Kramer Maximilian Marhold Michael Krainer Dmitry V. Enikeev Petr V. Glybochko Dietmar Tamandl Shahrokh F. Shariat Pascal Baltzer Source Type: research

Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 19 November 2019; doi:10.1038/s41391-019-0188-4Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 19, 2019 Category: Urology & Nephrology Authors: William S. Chen Eric L. Feng Rahul Aggarwal Adam Foye Tomasz M. Beer Joshi J. Alumkal Martin Gleave Kim N. Chi Robert E. Reiter Matthew B. Rettig Christopher P. Evans Eric J. Small Nima Sharifi Shuang G. Zhao Source Type: research

Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia
Prostate Cancer and Prostatic Diseases, Published online: 18 November 2019; doi:10.1038/s41391-019-0187-5Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 18, 2019 Category: Urology & Nephrology Authors: Kevin T. McVary Bradley Holland J. Randolf Beahrs Source Type: research

Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy
Prostate Cancer and Prostatic Diseases, Published online: 12 November 2019; doi:10.1038/s41391-019-0185-7Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 12, 2019 Category: Urology & Nephrology Authors: Joseph Marascio Daniel E. Spratt Jingbin Zhang Edouard J. Trabulsi Tiffany Le Worlanyo Sosu Sedzorme Whitney H. Beeler Elai Davicioni Bashar Dabbas Daniel W. Lin John L. Gore Matthew Bloom Mark Mann J. Ryan Mark Anne Calvaresi James L. Godwin Peter McCue Source Type: research

Feasibility and continence outcomes of extended prostatic urethral preservation during robot-assisted radical prostatectomy
Prostate Cancer and Prostatic Diseases, Published online: 07 November 2019; doi:10.1038/s41391-019-0173-yFeasibility and continence outcomes of extended prostatic urethral preservation during robot-assisted radical prostatectomy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 7, 2019 Category: Urology & Nephrology Authors: Luciano A. Nunez Bragayrac Ahmed A. Hussein Kristopher Attwood Elena Pop Gaybrielle James Jennifer Osei Christine Murekeysoni Eric C. Kauffman Source Type: research

Prostate cancer characteristics and cancer-specific mortality of Native American patients
Prostate Cancer and Prostatic Diseases, Published online: 06 November 2019; doi:10.1038/s41391-019-0184-8Prostate cancer characteristics and cancer-specific mortality of Native American patients (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 6, 2019 Category: Urology & Nephrology Authors: Marina Deuker Sophie Knipper Angela Pecoraro Carlotta Palumbo Giuseppe Rosiello Stefano Luzzago Zhe Tian Fred Saad Felix Chun Pierre I. Karakiewicz Source Type: research

Hyperpolarized 13C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study
Prostate Cancer and Prostatic Diseases, Published online: 04 November 2019; doi:10.1038/s41391-019-0180-zHyperpolarized 13C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 4, 2019 Category: Urology & Nephrology Authors: Hsin-Yu Chen Rahul Aggarwal Robert A. Bok Michael A. Ohliger Zi Zhu Philip Lee Jeremy W. Gordon Mark van Criekinge Lucas Carvajal James B. Slater Peder E. Z. Larson Eric J. Small John Kurhanewicz Daniel B. Vigneron Source Type: research

Adverse events related to abiraterone and enzalutamide treatment: analysis of the EudraVigilance database and meta-analysis of registrational phase III studies
Prostate Cancer and Prostatic Diseases, Published online: 04 November 2019; doi:10.1038/s41391-019-0182-xAdverse events related to abiraterone and enzalutamide treatment: analysis of the EudraVigilance database and meta-analysis of registrational phase III studies (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 4, 2019 Category: Urology & Nephrology Authors: Cosimo De Nunzio Riccardo Lombardo Giorgia Tema Olivia Voglino Angela Sica Valeria Baldassarri Antonio Nacchia Roberto Iacovelli Sergio Bracarda Andrea Tubaro Source Type: research

Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies
Prostate Cancer and Prostatic Diseases, Published online: 04 November 2019; doi:10.1038/s41391-019-0183-9Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 4, 2019 Category: Urology & Nephrology Authors: Elio Mazzone Francesco A. Mistretta Sophie Knipper Zhe Tian Carlotta Palumbo Giorgio Gandaglia Nicola Fossati Shahrokh F. Shariat Fred Saad Francesco Montorsi Markus Graefen Alberto Briganti Pierre I. Karakiewicz Source Type: research

Tobacco smoking and death from prostate cancer in US veterans
Prostate Cancer and Prostatic Diseases, Published online: 17 October 2019; doi:10.1038/s41391-019-0178-6Tobacco smoking and death from prostate cancer in US veterans (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 17, 2019 Category: Urology & Nephrology Authors: Paul Riviere Abhishek Kumar Elaine Luterstein Lucas K. Vitzthum Vinit Nalawade Reith R. Sarkar Alex K. Bryant John P. Einck Arno J. Mundt James D. Murphy Brent S. Rose Source Type: research

Exposure–response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 14 October 2019; doi:10.1038/s41391-019-0179-5Exposure–response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 14, 2019 Category: Urology & Nephrology Authors: M. van Nuland S. L. Groenland A. M. Bergman N. Steeghs H. Rosing N. Venekamp A. D. R. Huitema J. H. Beijnen Source Type: research

A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 14 October 2019; doi:10.1038/s41391-019-0176-8A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 14, 2019 Category: Urology & Nephrology Authors: Ashley E. Ross Paula J. Hurley Phuoc T. Tran Steven P. Rowe Benjamin Benzon Tanya O ’ Neal Carolyn Chapman Rana Harb Yelena Milman Bruce J. Trock Charles G. Drake Emmanuel S. Antonarakis Source Type: research

Lutetium-177 prostate-specific membrane antigen (PSMA) theranostics: practical nuances and intricacies
Prostate Cancer and Prostatic Diseases, Published online: 08 October 2019; doi:10.1038/s41391-019-0174-xLutetium-177 prostate-specific membrane antigen (PSMA) theranostics: practical nuances and intricacies (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 8, 2019 Category: Urology & Nephrology Authors: Amir Iravani John Violet Arun Azad Michael S. Hofman Source Type: research

The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 07 October 2019; doi:10.1038/s41391-019-0177-7The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 7, 2019 Category: Urology & Nephrology Authors: Yuqiu Ge Qianqian Shi Wenxi Yao Yang Cheng Gaoxiang Ma Source Type: research

United States trends in active surveillance or watchful waiting across patient socioeconomic status from 2010 to 2015
Prostate Cancer and Prostatic Diseases, Published online: 07 October 2019; doi:10.1038/s41391-019-0175-9United States trends in active surveillance or watchful waiting across patient socioeconomic status from 2010 to 2015 (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 7, 2019 Category: Urology & Nephrology Authors: Santino S. Butler Stacy Loeb Alexander P. Cole Cierra Zaslowe-Dude Vinayak Muralidhar Daniel W. Kim Edward M. Schaeffer Quoc-Dien Trinh Paul L. Nguyen Brandon A. Mahal Source Type: research

Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 09 September 2019; doi:10.1038/s41391-019-0171-0Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 9, 2019 Category: Urology & Nephrology Authors: Janet Baack Kukreja Tharakeswara K. Bathala Chad A. Reichard Patricia Troncoso Scott Delacroix Benjamin Davies Scott Eggener Marc Smaldone Mohummad Minhaj Siddiqui Matthew Tollefson Brian F. Chapin Source Type: research